Interesting how the price of a stock is mostly about perception. In 2010 the outstanding shares was 65m, sales at about $3.8m, they lost almost $1m, and people were willing to pay over $1/share for the stock. Today the share count is 70m, sales at about $3m, and it appears they are now able to make a profit, yet nobody wants to pay 3.5 cents for the stock.
They ran into road blocks, with the FDA being the big one I think. That’s probably why they are selling in international markets. I didn’t buy this stock because of the annual that’s due out; I don’t think there will be anything mind blowing in there (I would love to be wrong though). I just think this is the year the company/stock finally breaks out.